Th22 Cells Are an Important Source of IL-22 for Host Protection against Enteropathogenic Bacteria

Immunity

Volumn 37, Issue 6, 2012, Pages 1061-1075

  Basu, Rajatava ^a   O'Quinn, Darrell B ^a   Silberger, Daniel J ^a   Schoeb, Trenton R ^b   Fouser, Lynette ^c   Ouyang, Wenjun ^d   Hatton, Robin D ^a   Weaver, Casey T ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^c PFIZER INC   (United States)

^d GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 6; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL SURVIVAL; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CITROBACTER RODENTIUM; CONTROLLED STUDY; CYTOKINE PRODUCTION; HELPER CELL; HOST RESISTANCE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH17 CELL; TH22 CELL;

ANIMALS; CITROBACTER RODENTIUM; ENTEROBACTERIACEAE INFECTIONS; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; INTERLEUKIN-23; INTERLEUKIN-6; INTERLEUKINS; MICE; MICE, KNOCKOUT; MUCOUS MEMBRANE; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; RECEPTORS, ARYL HYDROCARBON; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTES, HELPER-INDUCER; TH17 CELLS;

EID: 84870876967     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.08.024     Document Type: Article

References (49)

1. Andoh A., Zhang Z., Inatomi O., Fujino S., Deguchi Y., Araki Y., Tsujikawa T., Kitoh K., Kim-Mitsuyama S., Takayanagi A., et al. Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 2005, 129:969-984.
2. Aujla S.J., Chan Y.R., Zheng M., Fei M., Askew D.J., Pociask D.A., Reinhart T.A., McAllister F., Edeal J., Gaus K., et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat. Med. 2008, 14:275-281.
3. Bry L., Brenner M.B. Critical role of T cell-dependent serum antibody, but not the gut-associated lymphoid tissue, for surviving acute mucosal infection with Citrobacter rodentium, an attaching and effacing pathogen. J. Immunol. 2004, 172:433-441.
4. Buonocore S., Ahern P.P., Uhlig H.H., Ivanov I.I., Littman D.R., Maloy K.J., Powrie F. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 2010, 464:1371-1375.
5. Cella M., Fuchs A., Vermi W., Facchetti F., Otero K., Lennerz J.K.M., Doherty J.M., Mills J.C., Colonna M. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 2009, 457:722-725.
6. Colonna M. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 2009, 31:15-23.
7. Dann S.M., Spehlmann M.E., Hammond D.C., Iimura M., Hase K., Choi L.J., Hanson E., Eckmann L. IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens. J. Immunol. 2008, 180:6816-6826.
8. Duhen T., Geiger R., Jarrossay D., Lanzavecchia A., Sallusto F. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 2009, 10:857-863.
9. Elsaesser H., Sauer K., Brooks D.G. IL-21 is required to control chronic viral infection. Science 2009, 324:1569-1572.
10. + T-cell IL-17 production. Immunology 2010, 131:183-191.
11. Eto D., Lao C., DiToro D., Barnett B., Escobar T.C., Kageyama R., Yusuf I., Crotty S. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS ONE 2011, 6:e17739.
12. H17 cells in the absence of TGF-β signalling. Nature 2010, 467:967-971.
13. Gurney A.L. IL-22, a Th1 cytokine that targets the pancreas and select other peripheral tissues. Int. Immunopharmacol. 2004, 4:669-677.
14. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 2005, 6:1123-1132.
15. Higgins L.M., Frankel G., Douce G., Dougan G., MacDonald T.T. Citrobacter rodentium infection in mice elicits a mucosal Th1 cytokine response and lesions similar to those in murine inflammatory bowel disease. Infect. Immun. 1999, 67:3031-3039.
16. Huber M., Brüstle A., Reinhard K., Guralnik A., Walter G., Mahiny A., von Löw E., Lohoff M. IRF4 is essential for IL-21-mediated induction, amplification, and stabilization of the Th17 phenotype. Proc. Natl. Acad. Sci. USA 2008, 105:20846-20851.
17. Ikeuchi H., Kuroiwa T., Hiramatsu N., Kaneko Y., Hiromura K., Ueki K., Nojima Y. Expression of interleukin-22 in rheumatoid arthritis: potential role as a proinflammatory cytokine. Arthritis Rheum. 2005, 52:1037-1046.
18. lo) CD4 T cells are controlled directly by IL-10 and cause IL-22-dependent intestinal pathology. J. Exp. Med. 2011, 208:1027-1040.
19. Kiss E.A., Vonarbourg C., Kopfmann S., Hobeika E., Finke D., Esser C., Diefenbach A. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011, 334:1561-1565.
20. Kolls J.K., McCray P.B., Chan Y.R. Cytokine-mediated regulation of antimicrobial proteins. Nat. Rev. Immunol. 2008, 8:829-835.
21. H17 differentiation by preventing Runx1-mediated activation of the gene encoding RORγt. Nat. Immunol. 2011, 12:96-104.
22. Lee Y.K., Turner H., Maynard C.L., Oliver J.R., Chen D., Elson C.O., Weaver C.T. Late developmental plasticity in the T helper 17 lineage. Immunity 2009, 30:92-107.
23. Liang S.C., Tan X.-Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., Fouser L.A. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 2006, 203:2271-2279.
24. H17 lineage. Nature 2006, 441:231-234.
25. Mukasa R., Balasubramani A., Lee Y.K., Whitley S.K., Weaver B.T., Shibata Y., Crawford G.E., Hatton R.D., Weaver C.T. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 2010, 32:616-627.
26. Mundy R., MacDonald T.T., Dougan G., Frankel G., Wiles S. Citrobacter rodentium of mice and man. Cell. Microbiol. 2005, 7:1697-1706.
27. Nurieva R., Yang X.O., Martinez G., Zhang Y., Panopoulos A.D., Ma L., Schluns K., Tian Q., Watowich S.S., Jetten A.M., Dong C. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 2007, 448:480-483.
28. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
29. Ouyang W., Rutz S., Crellin N.K., Valdez P.A., Hymowitz S.G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annu. Rev. Immunol. 2011, 29:71-109.
30. Ozaki K., Spolski R., Feng C.G., Qi C.-F., Cheng J., Sher A., Morse H.C., Liu C., Schwartzberg P.L., Leonard W.J. A critical role for IL-21 in regulating immunoglobulin production. Science 2002, 298:1630-1634.
31. Ramirez-Carrozzi V., Sambandam A., Luis E., Lin Z., Jeet S., Lesch J., Hackney J., Kim J., Zhou M., Lai J., et al. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat. Immunol. 2011, 12:1159-1166.
32. H17 cells. Nat. Immunol. 2011, 12:1238-1245.
33. Sawa S., Cherrier M., Lochner M., Satoh-Takayama N., Fehling H.J., Langa F., Di Santo J.P., Eberl G. Lineage relationship analysis of RORγt+ innate lymphoid cells. Science 2010, 330:665-669.
34. H17 differentiation. Nature 2009, 460:405-409.
35. Song X., Zhu S., Shi P., Liu Y., Shi Y., Levin S.D., Qian Y. IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens. Nat. Immunol. 2011, 12:1151-1158.
36. Sonnenberg G.F., Fouser L.A., Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-22. Nat. Immunol. 2011, 12:383-390.
37. + lymphoid tissue-inducer cells promote innate immunity in the gut. Immunity 2011, 34:122-134.
38. Takatori H., Kanno Y., Watford W.T., Tato C.M., Weiss G., Ivanov I.I., Littman D.R., O'Shea J.J. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J. Exp. Med. 2009, 206:35-41.
39. H2 cells. Nat. Immunol. 2009, 10:864-871.
40. H17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453:106-109.
41. Wiles S., Pickard K.M., Peng K., MacDonald T.T., Frankel G. In vivo bioluminescence imaging of the murine pathogen Citrobacter rodentium. Infect. Immun. 2006, 74:5391-5396.
42. Wolk K., Kunz S., Witte E., Friedrich M., Asadullah K., Sabat R. IL-22 increases the innate immunity of tissues. Immunity 2004, 21:241-254.
43. Wolk K., Witte E., Wallace E., Döcke W.-D., Kunz S., Asadullah K., Volk H.-D., Sterry W., Sabat R. IL-22 regulates the expression of genes responsible for antimicrobial defense, cellular differentiation, and mobility in keratinocytes: a potential role in psoriasis. Eur. J. Immunol. 2006, 36:1309-1323.
44. Wolk K., Witte E., Hoffmann U., Doecke W.-D., Endesfelder S., Asadullah K., Sterry W., Volk H.-D., Wittig B.M., Sabat R. IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohn's disease. J. Immunol. 2007, 178:5973-5981.
45. Wolk K., Witte E., Witte K., Warszawska K., Sabat R. Biology of interleukin-22. Semin. Immunopathol. 2010, 32:17-31.
46. Yi J.S., Du M., Zajac A.J. A vital role for interleukin-21 in the control of a chronic viral infection. Science 2009, 324:1572-1576.
47. Yoshida M., Masuda A., Kuo T.T., Kobayashi K., Claypool S.M., Takagawa T., Kutsumi H., Azuma T., Lencer W.I., Blumberg R.S. IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity. Springer Semin. Immunopathol. 2006, 28:397-403.
48. H17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007, 445:648-651.
49. Zheng Y., Valdez P.A., Danilenko D.M., Hu Y., Sa S.M., Gong Q., Abbas A.R., Modrusan Z., Ghilardi N., de Sauvage F.J., Ouyang W. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 2008, 14:282-289.